BrainStorm Granted Additional US Patent for Its Autologous Stem Cell Technology – Jewish Business News
BrainStorm Granted Additional US Patent for Its Autologous Stem Cell TechnologyJewish Business NewsBrainStorm Cell Therapeutics (otcqb:BCLI), a developer of adult stem cell technologies for neurodegenerative diseases, today announced that the U.S. Patent and Trademark Office has granted the company an additional patent for its autologous stem cell …BrainStorm wins additional US patent for its autologous … Continue reading
